SEELQ — Seelos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Seelos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	10.3	15.7	78.7	15.5	3
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.763
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11.1	17.5	83.5	22.7	5.4
Net Property, Plant And Equipment	—	—	0.039	0.072	0.015
Total Assets	11.1	17.5	83.5	22.7	5.42
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.8	7.43	8.29	25.2	38.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.1	14.9	26.2	33.4	38.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.007	2.57	57.3	-10.6	-33.5
Total Liabilities & Shareholders' Equity	11.1	17.5	83.5	22.7	5.42
Total Common Shares Outstanding